Mike Andrews in the News

Photo of Mike Andrews D. Michael "Mike" Andrews
Lead Attorney in Mesothelioma Lawsuits
 

Articles 1 to 10 of 88 for attorney Mike Andrews .

Plaintiffs' Steering Committee in BP Gulf oil spill litigation announces settlement in principle with BP

| March 5, 2012
The Plaintiffs' Steering Committee (PSC) spearheading the litigation surrounding the 2010 BP Gulf Oil Spill today announced that a settlement in principle has been reached with BP that will fully compensate hundreds of thousands of victims of the tragedy.

Beasley Allen shareholder Gibson Vance appointed to Troy University Board of Trustees

| February 29, 2012
C. Gibson Vance, a Troy University alumnus, has been named to the University's Board of Trustees by Alabama Gov. Robert Bentley. Vance is a shareholder in the Montgomery law firm of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Nissan recalls Infiniti sedans, SUVs and Juke crossovers for fuel tank leak

| February 27, 2012
Nissan North America has issued a recall of more than 79,000 vehicles for possible fuel tank leakage. This may increase the risk of a vehicle fire. Vehicles involved in the recall are certain 2011-2012 models of the Infiniti M sedan, the Infiniti QX sport-utility vehicle (SUV) and the Nissan Juke crossover vehicle.

More birth control pills recalled due to packaging error

| February 27, 2012
More birth control pills are being recalled due to packaging error that may leave women without adequate contraception and at risk for unintended pregnancy. The latest batch of pills are made by Glenmark Generics Inc. USA and involve seven lots of Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg. The recall comes five months after Qualitest Pharmaceuticals announced a massive recall of 1.4 million lots of birth control pills for a similar packaging error.

Cancer drug recalled due to sterility concerns

| February 27, 2012
Bedford Laboratories is recalling three lots of the cancer treatment Cytarabine for Injection, USP, I Gram per Vial, because the vials may not be sterile. This risk was determined following a post-release investigation of the manufacturing area.

Troy native, Beasley Allen shareholder Rhon Jones, serving on BP trial panel

The Troy Messenger | February 24, 2012
Rhon Jones, who was born in Troy and graduated from Charles Henderson High School, is one of 15 attorneys who were chosen for the Plaintiff’s Steering Committee in the multi-district litigation related to the Deepwater Horizon explosion an oil spill.

McNeil recalls half-million bottles of infants Tylenol Oral Suspension

| February 21, 2012
Approximately 574,000 bottles of infants Tylenol Oral Suspension, 1 Oz. Grape have been recalled due to complaints from consumers who reported difficulty using the Infants’ Tylenol SimpleMeasure dosing system. The system includes a dosing syringe, which the parent or caregiver inserts into a protective cover, or “flow restrictor,” at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe.

'Slalom Glider' slides recalled after reports of broken bones, serious injury

| February 17, 2012
Landscape Structures, Inc., of Delano, Minn., in conjunction with the U.S. Consumer Product Safety Commission (CPSC) has issued a nationwide recall for a molded plastic playground slide that poses a fall risk to children.

Evidence indicates link between combination HRT and breast cancer

| February 17, 2012
For years, drug companies touted the benefits of HRT. Marketing campaigns for medications like Premarin, Prempro and Provera targeted both women and their doctors, promising that the drugs could perform miracles. Manufacturers boasted these drugs could not only temper bothersome symptoms of menopause, including hot flashes, mood swings, and vaginal dryness, but they had the added benefit of protecting women against heart disease, a serious concern among older women. Use of these drugs was even encouraged for off-label uses, including the prevention of Alzheimer’s disease.

FDA issues warning about counterfeit of cancer drug Avastin

| February 15, 2012
The Food and Drug Administration (FDA) is warning doctors and patients that counterfeit versions of the cancer drug Avastin (bevacizumab) have been found on the market and may have been purchased and used by some medical practices in the United States.